1. Home
  2. CRL vs AXTA Comparison

CRL vs AXTA Comparison

Compare CRL & AXTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRL
  • AXTA
  • Stock Information
  • Founded
  • CRL 1947
  • AXTA 1910
  • Country
  • CRL United States
  • AXTA United States
  • Employees
  • CRL N/A
  • AXTA N/A
  • Industry
  • CRL Biotechnology: Commercial Physical & Biological Resarch
  • AXTA Paints/Coatings
  • Sector
  • CRL Health Care
  • AXTA Consumer Discretionary
  • Exchange
  • CRL Nasdaq
  • AXTA Nasdaq
  • Market Cap
  • CRL 7.3B
  • AXTA 6.7B
  • IPO Year
  • CRL 2000
  • AXTA 2014
  • Fundamental
  • Price
  • CRL $163.99
  • AXTA $31.81
  • Analyst Decision
  • CRL Buy
  • AXTA Buy
  • Analyst Count
  • CRL 14
  • AXTA 14
  • Target Price
  • CRL $186.00
  • AXTA $39.00
  • AVG Volume (30 Days)
  • CRL 804.9K
  • AXTA 2.5M
  • Earning Date
  • CRL 11-05-2025
  • AXTA 10-29-2025
  • Dividend Yield
  • CRL N/A
  • AXTA N/A
  • EPS Growth
  • CRL N/A
  • AXTA 51.22
  • EPS
  • CRL N/A
  • AXTA 2.04
  • Revenue
  • CRL $4,028,615,000.00
  • AXTA $5,198,000,000.00
  • Revenue This Year
  • CRL N/A
  • AXTA $0.82
  • Revenue Next Year
  • CRL $1.94
  • AXTA $2.97
  • P/E Ratio
  • CRL N/A
  • AXTA $15.59
  • Revenue Growth
  • CRL N/A
  • AXTA N/A
  • 52 Week Low
  • CRL $91.86
  • AXTA $27.58
  • 52 Week High
  • CRL $230.02
  • AXTA $41.66
  • Technical
  • Relative Strength Index (RSI)
  • CRL 56.33
  • AXTA 62.77
  • Support Level
  • CRL $157.20
  • AXTA $30.58
  • Resistance Level
  • CRL $165.22
  • AXTA $31.69
  • Average True Range (ATR)
  • CRL 3.97
  • AXTA 0.62
  • MACD
  • CRL 0.38
  • AXTA 0.05
  • Stochastic Oscillator
  • CRL 78.43
  • AXTA 77.31

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

About AXTA Axalta Coating Systems Ltd.

Axalta Coating Systems Ltd is a manufacturer, marketer and distributor of high-performance coatings systems. It operates in two segments, The Performance Coatings segment provides liquid and powder coatings solutions to a fragmented and local customer base. Its end markets include refinish and industrial. The Mobility Coatings segment relates to the provision of coating technologies to original equipment manufacturers of light and commercial vehicles. The company operates in the geographic areas of North America, EMEA countries, Asia-Pacific, and Latin America.

Share on Social Networks: